Mariya G. Ilchenko
Mariya G. Ilchenko has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Natalia A. Maksimova
National Medical Research Centre for Oncology
10 shared publications - Elena I. Agarkova
National Medical Research Centre for Oncology
5 shared publications - Marina A. Arzamastseva
National Medical Research Center of Oncology
4 shared publications - Anna S. Egorova
National Medical Research Centre for Oncology
3 shared publications - Elena Mikhaylovna Frantsiyants
National Medical Research Center of Oncology, Ministry of Health of Russia
3 shared publications - Irina Viktorovna Kaplieva
Rostov Research Institute of Oncology
3 shared publications
Latest Publications
- 23 January 2026
- Published by ECO-Vector LLC (Publications) in Kazan medical journal
- Vol. 107 (1) , 150-157
Granulomatous inflammation of the liver in children
Granulomatous inflammation of the liver (granulomatous hepatitis) is a rare condition characterized by granulomas within the hepatic parenchyma. It may result from infectious causes (tuberculosis and Epstein–Barr virus infection) as well as noninfectious etiologies (drug-induced liver injury and systemic diseases). Its diagnosis and management require a multidisciplinary approach. Four pediatric patients with granulomatous liver involvement underwent abdominal ultrasonography, computed tomography, magnetic resonance imaging, and liver trephine biopsy with subsequent histological and immunohistochemical examination. In addition, polymerase chain reaction and serological testing were performed to identify infectious agents. All patients demonstrated multiple focal hepatic lesions. In two of them, Epstein–Barr virus DNA was detected, and histological analysis confirmed granulomas composed of epithelioid cells and giant cells. Following biopsy and symptomatic therapy, a reduction in hepatic lesions was observed, with complete resolution documented after 3 months. Granulomatous hepatitis is frequently asymptomatic and requires comprehensive diagnostic evaluation, including liver biopsy. Treatment aimed at eliminating the underlying cause leads to a favorable outcome. Early diagnosis and timely therapy are essential to prevent progression to hepatic fibrosis and cirrhosis.
- 23 January 2026
- Published by ECO-Vector LLC (Publications) in Kazan medical journal
- Vol. 107 (1) , 150-157
Granulomatous inflammation of the liver in children
Granulomatous inflammation of the liver (granulomatous hepatitis) is a rare condition characterized by granulomas within the hepatic parenchyma. It may result from infectious causes (tuberculosis and Epstein–Barr virus infection) as well as noninfectious etiologies (drug-induced liver injury and systemic diseases). Its diagnosis and management require a multidisciplinary approach. Four pediatric patients with granulomatous liver involvement underwent abdominal ultrasonography, computed tomography, magnetic resonance imaging, and liver trephine biopsy with subsequent histological and immunohistochemical examination. In addition, polymerase chain reaction and serological testing were performed to identify infectious agents. All patients demonstrated multiple focal hepatic lesions. In two of them, Epstein–Barr virus DNA was detected, and histological analysis confirmed granulomas composed of epithelioid cells and giant cells. Following biopsy and symptomatic therapy, a reduction in hepatic lesions was observed, with complete resolution documented after 3 months. Granulomatous hepatitis is frequently asymptomatic and requires comprehensive diagnostic evaluation, including liver biopsy. Treatment aimed at eliminating the underlying cause leads to a favorable outcome. Early diagnosis and timely therapy are essential to prevent progression to hepatic fibrosis and cirrhosis.
- Open Access
- 19 February 2025
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 12 (1) , 52-64
Changes in the histological structure of Guerin's carcinoma in the model of tumor development on the background of diabetes mellitus
Purpose of the study. To create a model of tumor growth in the uterus in the context of diabetes mellitus (DM) and to study its morphological features. Materials and methods. The model was created using female non-linear white rats weighing 180–220 g (n = 15). Alloxan was prelim inarily injected at a dose of 150 mg/kg of weight intraperitoneally once (inducing DM). Twenty-four hours after injection, rats were anesthetized with xylazine-zolazepam, and a suspension of Guerin's carcinoma cells was transplanted into the uterine horn. Blood glucose levels, body weight, and trunk circumference were measured for two weeks. Fourteen days after transplantation, the rats were euthanized via CO₂ inhalation. The tumor affected abdominal cavity organs and uterus were then dissected, and histological sections (5–7 μm) were prepared and stained with hematoxylin and eosin staining, with a following microscopic examination. Results. At the time of tumor transplantation, the mean glucose level was 4.6 ± 0.4 mMol/L, 24 hours later it had increased to 25.4 ± 1.2 mMol/L, and it remained at this level until euthanasia. In the abdominal cavity, macroscopically, massive multinodular osseous tumor lesions of the uterus, mesentery, and internal organs were observed. Microscopically, numerous densely located cells with polymorphic hyperchromic nuclei and figures of pathological mitosis were observed, accompanied by significant vacuolization of cells that deviated from the typical characteristics of Guerin's carcinoma. Additionally, a mass of mucous elements was observed along the borders of nodules, suggestive of fringing. In the uterine tubes fused with tumor nodules, excessive mucus secretion, destruction of epithelium, and expansion of the interclavicular space were noted. Conclusion. The constructed model of orthotopic growth of Guerin's carcinoma in the rat uterus following the induction of DM by alloxan demonstrated that in a hyperglycemic environment, morphological alterations occur in both the tumor, reflecting its transition to a more aggressive mucinous low-differentiated form, and in the uterus with substantial damage to the uterine tube. Such alterations may intensify the proclivity of tumorigenesis in the uterus in the context of DM.
- 19 February 2025
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 12 (1) , 52-64
Open AccessChanges in the histological structure of Guerin's carcinoma in the model of tumor development on the background of diabetes mellitus
Purpose of the study. To create a model of tumor growth in the uterus in the context of diabetes mellitus (DM) and to study its morphological features. Materials and methods. The model was created using female non-linear white rats weighing 180–220 g (n = 15). Alloxan was prelim inarily injected at a dose of 150 mg/kg of weight intraperitoneally once (inducing DM). Twenty-four hours after injection, rats were anesthetized with xylazine-zolazepam, and a suspension of Guerin's carcinoma cells was transplanted into the uterine horn. Blood glucose levels, body weight, and trunk circumference were measured for two weeks. Fourteen days after transplantation, the rats were euthanized via CO₂ inhalation. The tumor affected abdominal cavity organs and uterus were then dissected, and histological sections (5–7 μm) were prepared and stained with hematoxylin and eosin staining, with a following microscopic examination. Results. At the time of tumor transplantation, the mean glucose level was 4.6 ± 0.4 mMol/L, 24 hours later it had increased to 25.4 ± 1.2 mMol/L, and it remained at this level until euthanasia. In the abdominal cavity, macroscopically, massive multinodular osseous tumor lesions of the uterus, mesentery, and internal organs were observed. Microscopically, numerous densely located cells with polymorphic hyperchromic nuclei and figures of pathological mitosis were observed, accompanied by significant vacuolization of cells that deviated from the typical characteristics of Guerin's carcinoma. Additionally, a mass of mucous elements was observed along the borders of nodules, suggestive of fringing. In the uterine tubes fused with tumor nodules, excessive mucus secretion, destruction of epithelium, and expansion of the interclavicular space were noted. Conclusion. The constructed model of orthotopic growth of Guerin's carcinoma in the rat uterus following the induction of DM by alloxan demonstrated that in a hyperglycemic environment, morphological alterations occur in both the tumor, reflecting its transition to a more aggressive mucinous low-differentiated form, and in the uterus with substantial damage to the uterine tube. Such alterations may intensify the proclivity of tumorigenesis in the uterus in the context of DM.
- Open Access
- 13 November 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (4) , 6-13
Intravenous radionuclide therapy with radium chloride [223Ra] in patients with bone metastases from castration-resistant prostate cancer
Purpose of the study. Assessment of clinical safety and effectiveness of radium‑223 in patients with bone metastases from castration-resistant prostate cancer.Patients and methods. The study involved materials on 15 patients with bone metastases from castration-resistant prostate cancer aged 58–81 years, with the mean age of 67.2 ± 6.5 years, who were examined and received full treatment with 6 intravenous injections of radium‑223 chloride [223Ra] at the National Medical Research Centre for Oncology. Most patients (73.3 %) showed ECOG 1 performance status. Pain syndrome before the treatment was registered in 12 (80 %) patients.Results. Evaluation of the tolerability of radium chloride did not show hematological reactions such as anemia and thrombocytopenia. One patient had grade II intestinal toxicity after the 3rd injection managed with medication. Assessment of indirect signs of the treatment effectiveness demonstrated that 6 people showed an increase in PSA during treatment, while alkaline phosphatase levels were within normal range indicating no bone destruction. 8 of 12 patients with pain syndrome showed its relief during the therapy. The following results were obtained during a follow-up examination after 3 months in 15 patients who received the full treatment course: stabilization in 8 patients; improvement in 4 patients with decreased metabolic activity and lower numbers of metastatic foci; progression with the appearance of new metastatic foci in the bones in 3 patients.Conclusion. Radium chloride showed good results in the treatment of patients with bone metastases from castration-resistant prostate cancer. Low toxicity and improvement in the quality of life by pain relief make this treatment technique promising.
- 13 November 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (4) , 6-13
Open AccessIntravenous radionuclide therapy with radium chloride [223Ra] in patients with bone metastases from castration-resistant prostate cancer
Purpose of the study. Assessment of clinical safety and effectiveness of radium‑223 in patients with bone metastases from castration-resistant prostate cancer.Patients and methods. The study involved materials on 15 patients with bone metastases from castration-resistant prostate cancer aged 58–81 years, with the mean age of 67.2 ± 6.5 years, who were examined and received full treatment with 6 intravenous injections of radium‑223 chloride [223Ra] at the National Medical Research Centre for Oncology. Most patients (73.3 %) showed ECOG 1 performance status. Pain syndrome before the treatment was registered in 12 (80 %) patients.Results. Evaluation of the tolerability of radium chloride did not show hematological reactions such as anemia and thrombocytopenia. One patient had grade II intestinal toxicity after the 3rd injection managed with medication. Assessment of indirect signs of the treatment effectiveness demonstrated that 6 people showed an increase in PSA during treatment, while alkaline phosphatase levels were within normal range indicating no bone destruction. 8 of 12 patients with pain syndrome showed its relief during the therapy. The following results were obtained during a follow-up examination after 3 months in 15 patients who received the full treatment course: stabilization in 8 patients; improvement in 4 patients with decreased metabolic activity and lower numbers of metastatic foci; progression with the appearance of new metastatic foci in the bones in 3 patients.Conclusion. Radium chloride showed good results in the treatment of patients with bone metastases from castration-resistant prostate cancer. Low toxicity and improvement in the quality of life by pain relief make this treatment technique promising.
- 16 October 2024
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 105 (6) , 1029-1036
Malignant melanotic nerve sheath tumor
Malignant melanotic nerve sheath tumor, previously melanotic schwannoma, is a rare peripheral nerve sheath tumor composed of melanin-producing Schwann cells, often clinically misdiagnosed as melanoma. It is an uncommon neoplasm with unpredictable biological behavior and varying treatments. Despite its histologic features indicative of benignity, including a low proliferative index, its clinical course is frequently malignant, with a high local recurrence rate and metastatic potential. The distinctive characteristics of malignant melanotic nerve sheath tumor include a relatively young patient age, signs of Carney complex, and psammoma bodies within the tumor. This study presents a case of a patient with malignant melanotic nerve sheath tumor located in the neck with a recurrent clinical course who underwent two surgical procedures. Microscopic and immunohistochemical evaluation of postoperative specimens showed positivity for melanoma markers, absence of psammoma bodies, and low mitotic activity. The clinical course of the disease was malignant, with recurrence developing in the postoperative scar. Diagnosing malignant melanotic nerve sheath tumor is radiologically and pathologically challenging. Multidisciplinary collaboration among the surgeon, radiologist, and pathologist; understanding the lesion’s anatomical context; and close attention to histopathologic findings are critical for establishing an accurate diagnosis.
- 16 October 2024
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 105 (6) , 1029-1036
Malignant melanotic nerve sheath tumor
Malignant melanotic nerve sheath tumor, previously melanotic schwannoma, is a rare peripheral nerve sheath tumor composed of melanin-producing Schwann cells, often clinically misdiagnosed as melanoma. It is an uncommon neoplasm with unpredictable biological behavior and varying treatments. Despite its histologic features indicative of benignity, including a low proliferative index, its clinical course is frequently malignant, with a high local recurrence rate and metastatic potential. The distinctive characteristics of malignant melanotic nerve sheath tumor include a relatively young patient age, signs of Carney complex, and psammoma bodies within the tumor. This study presents a case of a patient with malignant melanotic nerve sheath tumor located in the neck with a recurrent clinical course who underwent two surgical procedures. Microscopic and immunohistochemical evaluation of postoperative specimens showed positivity for melanoma markers, absence of psammoma bodies, and low mitotic activity. The clinical course of the disease was malignant, with recurrence developing in the postoperative scar. Diagnosing malignant melanotic nerve sheath tumor is radiologically and pathologically challenging. Multidisciplinary collaboration among the surgeon, radiologist, and pathologist; understanding the lesion’s anatomical context; and close attention to histopathologic findings are critical for establishing an accurate diagnosis.
- Open Access
- 30 August 2024
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 44 (4) , 105-112
Age-related characteristics of the content and activity of certain components of the blood fibrinolytic system in cases of uterine cancer
Uterine cancer (UC) is the third most common cancer in women in Russia. Knowledge of age-specific features of the fibrinolytic system in patients with UC can be useful in terms of improving its pathogenetic therapy. Aim of the study was to investigate the peculiarities of the content and activity of some components of the fibrinolytic system in the blood of UC patients of different age groups. Material and methods. 30 healthy women (donors) and 56 patients with uterine cancer T1a-2N0M0, adenocarcinoma G1–G3 were divided into subgroups according to age: reproductive, perimenopause and menopause. ELISA of urokinase (u-PA), its receptor (u-PAR) and its inhibitor (PAI-1), tissue-type plasminogen activator (t-PA) content were performed in blood collected before treatment. Results. In reproductive UC patients, inhibitor u-PA (PAI-1) activity increased 14-fold (hereinafter the difference is statistically significant, p < 0.05) and content increased 2.9-fold, while receptor u-PA (u-PAR) level decreased 1.7-fold compared to reproductive donors. Perimenopausal UC patients showed a 3.3-fold increase in PAI-1 content and a 6.3-fold increase in PAI-1 activity compared to perimenopausal donors, t-PA concentration decreased 1.3-fold relative to donors and was 1.9-fold lower than in reproductive UC patients. In menopausal patients with UC, the activity and content of PAI-1 enhanced 5.5-fold and 4.5-fold, respectively, compared to donors. Additionally, they were 2.1-fold and 1.2-fold lower than in reproductive UC patients. The activity of u-PA increased 2.6-fold, reaching the values of reproductive UC patients. The activity of t-PA was 1.3-fold higher than in donors, but did not differ from the activity in other RTM patients, while the level of t-PA occupied an intermediate position between the corresponding indices in young UC patients (it was 1.4-fold lower) and perimenopausal UC patients (it was 1.4-fold higher). Conclusions. The development of UC is accompanied by an imbalance of components of the fibrinolytic system in the blood, depending on the age of women, with a minimum spectrum of changes in the indicators in reproductive patients and maximum - in menopause patients, which indicates the pathognomonicity of these factors in PTM and requires an individual approach to the management of such patients.
- 30 August 2024
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 44 (4) , 105-112
Open AccessAge-related characteristics of the content and activity of certain components of the blood fibrinolytic system in cases of uterine cancer
Uterine cancer (UC) is the third most common cancer in women in Russia. Knowledge of age-specific features of the fibrinolytic system in patients with UC can be useful in terms of improving its pathogenetic therapy. Aim of the study was to investigate the peculiarities of the content and activity of some components of the fibrinolytic system in the blood of UC patients of different age groups. Material and methods. 30 healthy women (donors) and 56 patients with uterine cancer T1a-2N0M0, adenocarcinoma G1–G3 were divided into subgroups according to age: reproductive, perimenopause and menopause. ELISA of urokinase (u-PA), its receptor (u-PAR) and its inhibitor (PAI-1), tissue-type plasminogen activator (t-PA) content were performed in blood collected before treatment. Results. In reproductive UC patients, inhibitor u-PA (PAI-1) activity increased 14-fold (hereinafter the difference is statistically significant, p < 0.05) and content increased 2.9-fold, while receptor u-PA (u-PAR) level decreased 1.7-fold compared to reproductive donors. Perimenopausal UC patients showed a 3.3-fold increase in PAI-1 content and a 6.3-fold increase in PAI-1 activity compared to perimenopausal donors, t-PA concentration decreased 1.3-fold relative to donors and was 1.9-fold lower than in reproductive UC patients. In menopausal patients with UC, the activity and content of PAI-1 enhanced 5.5-fold and 4.5-fold, respectively, compared to donors. Additionally, they were 2.1-fold and 1.2-fold lower than in reproductive UC patients. The activity of u-PA increased 2.6-fold, reaching the values of reproductive UC patients. The activity of t-PA was 1.3-fold higher than in donors, but did not differ from the activity in other RTM patients, while the level of t-PA occupied an intermediate position between the corresponding indices in young UC patients (it was 1.4-fold lower) and perimenopausal UC patients (it was 1.4-fold higher). Conclusions. The development of UC is accompanied by an imbalance of components of the fibrinolytic system in the blood, depending on the age of women, with a minimum spectrum of changes in the indicators in reproductive patients and maximum - in menopause patients, which indicates the pathognomonicity of these factors in PTM and requires an individual approach to the management of such patients.
- Open Access
- 21 August 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (3) , 24-37
Age-related features of some plasminogen activation system components content and activity in the blood of benign and malignant uterine body tumors
Purpose of the study. Is to determine the features in the content and activity of some components of the plasminogen activation system in the blood of patients of different ages with leiomyomas (LM) and uterine corpus endometrial cancer (UCEC). Patients and methods. The study was carried out in patients with LM (n = 35) and UCEC T1a-2N0M0 (n = 56) of reproductive, perimenopausal and postmenopausal ages. Using ELISA methods, the content and activity of urokinase (u-PA), tissue plasminogen activator (t-PA), their inhibitor PAI-1, as well as the content of the soluble form of the u-PA receptor (su-PAR) were determined in the blood of patients. The Student´s test was used for statistical processing. Results. Regardless of the nature of the uterus tumor, it has been noted a significant increase in the activity and blood level of PAI-1 (up to 8 times, p < 0.01), especially pronounced in patients with UCEC of reproductive age. It was combined with the absence of changes or with a decreasing in blood level of su-PAR by more than 40 % (p < 0.05). We observed a rise of u-PA blood level without changes in one´s activity in patients with LM of perimenopausal age. And in patients with LM and UCEC of postmenopausal age an increase in u-PA blood level as well as elevation of u-PA activity (up to 3.9 times, p < 0.01–0.05) were noted. There was an increase in the calculated t-PA index (activity per unit mass) by 1.4–2.8 times (p < 0.05) in the most patients. The indicators of LM patients were characterized by the minimum value of the ratio “t-PA activity/u-PA activity in the blood” among all studied subgroups of patients. Age-related features of the researched parameters were observed more often in the cases of LM than in the cases of UCEC. The most pronounced differences between LM and UCEC were observed in patients of reproductive and postmenopausal age, characterized by stable hormonal levels. Conclusion. The participation of the plasminogen activation system in the pathogenesis of tumor lesions of the uterine body has been shown. The system’s “response” to the development of tumors in the uterus has both general characteristics and features that depend on the nature of the tumors and on the age-specific hormonal regulation of the body, which are most pronounced in postmenopausal women. The results obtained can be used in research aimed at clarifying the targets of targeted therapy for LM and UCEC in accordance with the age of patients.
- 21 August 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (3) , 24-37
Open AccessAge-related features of some plasminogen activation system components content and activity in the blood of benign and malignant uterine body tumors
Purpose of the study. Is to determine the features in the content and activity of some components of the plasminogen activation system in the blood of patients of different ages with leiomyomas (LM) and uterine corpus endometrial cancer (UCEC). Patients and methods. The study was carried out in patients with LM (n = 35) and UCEC T1a-2N0M0 (n = 56) of reproductive, perimenopausal and postmenopausal ages. Using ELISA methods, the content and activity of urokinase (u-PA), tissue plasminogen activator (t-PA), their inhibitor PAI-1, as well as the content of the soluble form of the u-PA receptor (su-PAR) were determined in the blood of patients. The Student´s test was used for statistical processing. Results. Regardless of the nature of the uterus tumor, it has been noted a significant increase in the activity and blood level of PAI-1 (up to 8 times, p < 0.01), especially pronounced in patients with UCEC of reproductive age. It was combined with the absence of changes or with a decreasing in blood level of su-PAR by more than 40 % (p < 0.05). We observed a rise of u-PA blood level without changes in one´s activity in patients with LM of perimenopausal age. And in patients with LM and UCEC of postmenopausal age an increase in u-PA blood level as well as elevation of u-PA activity (up to 3.9 times, p < 0.01–0.05) were noted. There was an increase in the calculated t-PA index (activity per unit mass) by 1.4–2.8 times (p < 0.05) in the most patients. The indicators of LM patients were characterized by the minimum value of the ratio “t-PA activity/u-PA activity in the blood” among all studied subgroups of patients. Age-related features of the researched parameters were observed more often in the cases of LM than in the cases of UCEC. The most pronounced differences between LM and UCEC were observed in patients of reproductive and postmenopausal age, characterized by stable hormonal levels. Conclusion. The participation of the plasminogen activation system in the pathogenesis of tumor lesions of the uterine body has been shown. The system’s “response” to the development of tumors in the uterus has both general characteristics and features that depend on the nature of the tumors and on the age-specific hormonal regulation of the body, which are most pronounced in postmenopausal women. The results obtained can be used in research aimed at clarifying the targets of targeted therapy for LM and UCEC in accordance with the age of patients.
- 15 August 2022
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 103 (4) , 688-695
Experience of simultaneous use of single-photon emission and X-ray computed tomography in cancer patients with fibrous dysplasia
Aim to present the results of using single-photon emission computed tomography combined with X-ray computed tomography in the process of diagnosing osteodestructive changes in cancer patients with a rare comorbidity fibrous dysplasia. In the consultative and diagnostic department of the Federal State Budgetary Institution National Medical Research Center of Oncology of the Ministry of Health of Russia, Rostov-on-Don, in 2021, 2 patients with fibrous dysplasia of the skull bones and synchronous oncological diseases were examined. The patients underwent a complex of diagnostic tests: spiral X-ray computed tomography of the head, chest, abdominal cavity and small pelvis, bone scintigraphy, single-photon emission computed tomography combined with X-ray computed tomography of the skeleton bones, and puncture biopsy under ultrasound control. The described clinical observations clearly demonstrate examples of a phased diagnostic oncological search in patients without pathognomonic clinical manifestations and with multiple lesions of the skull bones. An increase in diagnostic information content in the differential diagnosis of fibrous dysplasia of the skeleton bones and bone metastases is facilitated by single-photon emission computed tomography combined with X-ray computed tomography. The combination of these two hybrid technologies provides an opportunity to simultaneous determination of the volume and localization of lesions, timely conduction of differential diagnostics and, in turn, maximum optimization of the examination and management of patients in this category.
- 15 August 2022
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 103 (4) , 688-695
Experience of simultaneous use of single-photon emission and X-ray computed tomography in cancer patients with fibrous dysplasia
Aim to present the results of using single-photon emission computed tomography combined with X-ray computed tomography in the process of diagnosing osteodestructive changes in cancer patients with a rare comorbidity fibrous dysplasia. In the consultative and diagnostic department of the Federal State Budgetary Institution National Medical Research Center of Oncology of the Ministry of Health of Russia, Rostov-on-Don, in 2021, 2 patients with fibrous dysplasia of the skull bones and synchronous oncological diseases were examined. The patients underwent a complex of diagnostic tests: spiral X-ray computed tomography of the head, chest, abdominal cavity and small pelvis, bone scintigraphy, single-photon emission computed tomography combined with X-ray computed tomography of the skeleton bones, and puncture biopsy under ultrasound control. The described clinical observations clearly demonstrate examples of a phased diagnostic oncological search in patients without pathognomonic clinical manifestations and with multiple lesions of the skull bones. An increase in diagnostic information content in the differential diagnosis of fibrous dysplasia of the skeleton bones and bone metastases is facilitated by single-photon emission computed tomography combined with X-ray computed tomography. The combination of these two hybrid technologies provides an opportunity to simultaneous determination of the volume and localization of lesions, timely conduction of differential diagnostics and, in turn, maximum optimization of the examination and management of patients in this category.
- Open Access
- 21 February 2022
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 3 (1) , 40-45
Potential of sonography in diagnosis of tongue tumors
Purpose of the study. An analysis of sonography potential in the primary diagnosis and clinical staging of tongue cancer.Patients and methods. The study included 18 patients aged 40–70 years with tongue tumors. The majority accounted males – 14 (77.7 %). Women were represented by 4 (22.2 %) examinees. Ultrasound examinations were performed using expert-class ultrasound systems with broadband linear multifrequency transducers. Transoral examination with linear transducers required tumor location in the anterior and lateral parts of the oral tongue. During ultrasound examinations we evaluated: tumor shape, tumor invasion depth; tumor sizes – width and thickness; tumor echogenicity and structure; tumor vascularization in Doppler modes. The results were compared with the data of histological examination.Results. Transoral ultrasound examination of patients with tongue cancer allows clear visualization of the tumor and assessment of it’s spread. The study showed that the round shape of tongue tumors prevailed in 13 (72.2 %) patients, the tumor echo structure in 10 (55.5 %) was heterogeneous, the contours were even and clear in the majority of patients – 13 (72.2 %), all tumors showed a reduced acoustic density, the depth of invasion ranged from 2 to 6 mm in 8 (44.4 %) patients and exceeded 6 mm in 6 (33.3 %) patients, which corresponded to stages III and IV of the diseas. Doppler ultrasonography recorded intense intratumoral blood flow in 100 % of cases. In 8 (44.4 %) cases, metastatic lesions of the cervical lymph nodes were observed.Conclusion. Transoral ultrasound diagnosis of tongue cancer is a highly informative, safe and modern method providing surgeons with information that helps in choosing the scope of surgical treatment and in determining the disease prognosis at the preoperative stage. The accuracy of the method was 87 %, the sensitivity was 85 %, and the specificity was 86.2 %.
- 21 February 2022
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 3 (1) , 40-45
Open AccessPotential of sonography in diagnosis of tongue tumors
Purpose of the study. An analysis of sonography potential in the primary diagnosis and clinical staging of tongue cancer.Patients and methods. The study included 18 patients aged 40–70 years with tongue tumors. The majority accounted males – 14 (77.7 %). Women were represented by 4 (22.2 %) examinees. Ultrasound examinations were performed using expert-class ultrasound systems with broadband linear multifrequency transducers. Transoral examination with linear transducers required tumor location in the anterior and lateral parts of the oral tongue. During ultrasound examinations we evaluated: tumor shape, tumor invasion depth; tumor sizes – width and thickness; tumor echogenicity and structure; tumor vascularization in Doppler modes. The results were compared with the data of histological examination.Results. Transoral ultrasound examination of patients with tongue cancer allows clear visualization of the tumor and assessment of it’s spread. The study showed that the round shape of tongue tumors prevailed in 13 (72.2 %) patients, the tumor echo structure in 10 (55.5 %) was heterogeneous, the contours were even and clear in the majority of patients – 13 (72.2 %), all tumors showed a reduced acoustic density, the depth of invasion ranged from 2 to 6 mm in 8 (44.4 %) patients and exceeded 6 mm in 6 (33.3 %) patients, which corresponded to stages III and IV of the diseas. Doppler ultrasonography recorded intense intratumoral blood flow in 100 % of cases. In 8 (44.4 %) cases, metastatic lesions of the cervical lymph nodes were observed.Conclusion. Transoral ultrasound diagnosis of tongue cancer is a highly informative, safe and modern method providing surgeons with information that helps in choosing the scope of surgical treatment and in determining the disease prognosis at the preoperative stage. The accuracy of the method was 87 %, the sensitivity was 85 %, and the specificity was 86.2 %.
- Open Access
- 29 March 2021
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 2 (1) , 6-13
Optimization of planning radionuclide diagnostic tests in osteoscintigraphy
Purpose of the study. Determining maximum possible number of high-quality radionuclide studies by days of the generator operation.Materials and methods. We studied the factors influencing the capacity of radionuclide diagnostic tests in osteoscintigraphy (OSG) by days of service life of a 99mTc generator GT-4K. The OSG capacity, the required resource of 99mTc and its efficiency in OSG were calculated. The optimal days for the generator delivery were determined.The Pirfotech 99mTc radiopharmaceutical (RFP) prepared with the generator was used for OSG.Scanning, data collection and processing of results were carried out on gamma-cameras of the systems Signature Series, Symbia T16 Siemens, and syngo M1 Applications VB10 Siemens.Parameters of the radioactivity of 99mTc were processed by mathematical methods using the Excel program.Results. We revealed specific factors influencing the OSG capacity: 1) three-hour accumulation of RFP after its administration to the patient; 2) generator activity by days of its operation; 3) the day of the week of the generator delivery. We calculated quantitative indicators of the maximum possible OSG capacity during the generator operation (maximum number of OSG procedures by days of operation, total capacity, preferred day of the week for the generator delivery).Conclusion. The most significant factors in optimal OSG planning by days of the generator operation are the generator specifications, quantity and frequency of generator supply, provision of gamma-cameras.The described technique for scheduling diagnostic procedures can be useful for the efficient use of the generator system which ensures the maximum amount of high-quality RFP from the generator eluate and contributes to the objectification of the cancer process in order to choose the treatment tactics.
- 29 March 2021
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 2 (1) , 6-13
Open AccessOptimization of planning radionuclide diagnostic tests in osteoscintigraphy
Purpose of the study. Determining maximum possible number of high-quality radionuclide studies by days of the generator operation.Materials and methods. We studied the factors influencing the capacity of radionuclide diagnostic tests in osteoscintigraphy (OSG) by days of service life of a 99mTc generator GT-4K. The OSG capacity, the required resource of 99mTc and its efficiency in OSG were calculated. The optimal days for the generator delivery were determined.The Pirfotech 99mTc radiopharmaceutical (RFP) prepared with the generator was used for OSG.Scanning, data collection and processing of results were carried out on gamma-cameras of the systems Signature Series, Symbia T16 Siemens, and syngo M1 Applications VB10 Siemens.Parameters of the radioactivity of 99mTc were processed by mathematical methods using the Excel program.Results. We revealed specific factors influencing the OSG capacity: 1) three-hour accumulation of RFP after its administration to the patient; 2) generator activity by days of its operation; 3) the day of the week of the generator delivery. We calculated quantitative indicators of the maximum possible OSG capacity during the generator operation (maximum number of OSG procedures by days of operation, total capacity, preferred day of the week for the generator delivery).Conclusion. The most significant factors in optimal OSG planning by days of the generator operation are the generator specifications, quantity and frequency of generator supply, provision of gamma-cameras.The described technique for scheduling diagnostic procedures can be useful for the efficient use of the generator system which ensures the maximum amount of high-quality RFP from the generator eluate and contributes to the objectification of the cancer process in order to choose the treatment tactics.
- Open Access
- 1 January 2021
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №3 2021,p. 3
ASSESSMENT OF EFFICACY OF OSTEOMODELLING THERAPY IN PATIENTS WITH HORMONE-DEPENDENT BREAST CANCER
- 1 January 2021
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №3 2021,p. 3
Open AccessASSESSMENT OF EFFICACY OF OSTEOMODELLING THERAPY IN PATIENTS WITH HORMONE-DEPENDENT BREAST CANCER